TABLE 1.
Diet type | Week8 | Week14 | Week20 | ||||||
---|---|---|---|---|---|---|---|---|---|
Con | OP | OR | Con | OP | OR | Con | OP | OR | |
Liver | |||||||||
T‐AOC (U/mg prot) | 0.88 ± 0.06 | 0.76 ± 0.12* | 0.81 ± 0.06 | 0.90 ± 0.15 | 0.75 ± 0.14* | 1.01 ± 0.18# | 0.71 ± 0.10 | 0.55 ± 0.07 | 0.67 ± 0.10# |
MDA (U/mg prot) | 2.14 ± 0.51 | 2.76 ± 0.20* | 2.43 ± 0.53# | 2.02 ± 0.11 | 3.37 ± 0.33* | 2.25 ± 0.37# | 2.02 ± 0.39 | 4.25 ± 0.39* | 2.27 ± 0.48# |
GSH/GSSG | 3.19 ± 0.28 | 2.99 ± 0.22 | 3.54 ± 0.35 | 2.38 ± 0.24 | 2.18 ± 0.12 | 3.31 ± 0.18*# | 2.62 ± 0.32 | 1.91 ± 0.07* | 2.27 ± 0.19 |
ROS (103AUC/μl) | 1.01 ± 0.06 | 1.52 ± 0.63* | 0.77 ± 0.18*# | 1.03 ± 0.06 | 1.53 ± 0.38* | 1.30 ± 0.25 | 1.02 ± 0.21 | 1.89 ± 0.74* | 1.74 ± 0.95* |
Gastrocnemius | |||||||||
T‐AOC (U/mg prot) | 0.27 ± 0.04 | 0.25 ± 0.03 | 0.38 ± 0.06*# | 0.37 ± 0.08 | 0.28 ± 0.07* | 0.47 ± 0.03# | 1.10 ± 0.08 | 0.76 ± 0.03* | 1.02 ± 0.05 |
MDA (U/mg prot) | 1.78 ± 0.22 | 2.58 ± 0.31* | 1.79 ± 0.44# | 3.94 ± 0.64 | 4.83 ± 0.69* | 3.56 ± 0.82# | 2.72 ± 0.51 | 3.93 ± 0.51* | 3.22 ± 0.13# |
GSH/GSSG | 4.66 ± 0.4 | 4.02 ± 0.24* | 4.45 ± 0.21# | 4.61 ± 0.29 | 4.65 ± 0.25 | 4.76 ± 0.34 | 6.45 ± 0.24 | 5.74 ± 0.12* | 6.02 ± 0.06 |
ROS (103AUC/ul) | 1.03 ± 0.13 | 1.13 ± 0.18 | 0.90 ± 0.11# | 1.01 ± 0.29 | 1.27 ± 0.19* | 1.09 ± 0.25 | 1.01 ± 0.14 | 1.35 ± 0.08* | 1.28 ± 0.07* |
Serum | |||||||||
T‐AOC (U/mg prot) | 5.33 ± 0.34 | 4.49 ± 0.23* | 4.79 ± 0.24 | 5.60 ± 0.21 | 5.04 ± 0.35* | 5.68 ± 0.14# | 5.44 ± 0.19 | 4.14 ± 0.20* | 5.18 ± 0.37# |
MDA (U/mg prot) | 4.90 ± 0.41 | 6.12 ± 0.38* | 5.44 ± 0.57 | 4.90 ± 0.51 | 6.35 ± 0.56* | 6.25 ± 0.29* | 2.56 ± 0.54 | 4.17 ± 0.35* | 3.15 ± 0.42# |
GSH/GSSG | 7.58 ± 0.14 | 4.07 ± 0.16* | 6.49 ± 0.20# | 7.56 ± 0.34 | 5.46 ± 0.24* | 7.47 ± 0.31# | 7.12 ± 0.29 | 5.43 ± 0.14* | 6.89 ± 0.11# |
ROS (103AUC/μl) | 1.02 ± 0.14 | 1.27 ± 0.22* | 1.06 ± 0.25 | 1.10 ± 0.16 | 1.30 ± 0.24* | 1.25 ± 0.32 | 1.00 ± 0.28 | 1.45 ± 0.37* | 1.16 ± 0.35# |
Data were presented as mean ± SEM. Con, control group; OP, obesity‐prone; OR, obesity‐resistant. * p < .05 versus Con; # p < .05 versus OP.